alexa Circulating Plasma Blasts From Patients With Rheumatoid Arthritis Preferentially Produce Anticitrullinated Protein Antibodies
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Clinical & Cellular Immunology
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Kaihong Su
ScientificTracks Abstracts: J Clin Cell Immunol
DOI: 10.4172/2155-9899.S1.017
Abstract
Anti-citrullinated protein antibodies (ACPAs) are highly specific serological markers for rheumatoid arthritis (RA) and are also believed to contribute to RA pathogenesis. However, the cellular and molecular basis of ACPA production is not fully understood. Using a single cell PCR-based antibody cloning technology, we analyzed if circulating plasmablasts (CD19dimCD27highCD20-) in RA patients produce ACPAs. Among the 195 antibodies generated from 6ACPA+RA patients, 18.5% (ranging 6.5-27.6%) specifically recognize citrullinated antigens, but not their native forms. However, none of the antibodies generated from ACPA-RA patient or healthy donors reacted with citrullinated antigens. Detailed sequence analyses showed that the IgH and IgL genes encoding these ACPAs are highly mutated. Reversion of the mutated IgH and IgL genes to their corresponding germline genes completely eliminated their ACPA reactivity, suggesting that the generation of circulating ACPAs is an antigen driven process. To identify the antigen sources for ACPAs, we found that about half of the ACPAs react with outer membrane proteins from Porphyromona gingivalis (P. ging) and/or citrullinated P. gingenolase. Some ACPAs also react with auto-antigens released in the human neutrophil extracellular traps. These results suggest that circulating plasmablasts in RA patients are a source of ACPA production and the generation of ACPAs is driven by both exogenous bacterial antigens and citrullinated self-antigens. Our data thus identify circulating plasmablasts as potential therapeutic targets and provide a mechanism for previous findings that plasmablasts in the blood predict non-response to anti-CD20 therapy in RA patients.
Biography
Kaihong Su obtained her Doctorate degree and Post-doctoral training from the University of Alabama at Birmingham (UAB). After being a faculty member at UAB for 5 years, she joined the University of Nebraska Medical Center in 2008 to continue her research. The long-term goal of her lab is to understand the molecular mechanisms for autoimmune diseases, including SLE and RA. She has published 26 papers in reputed journals and served as ad-hoc Reviewer for a number of scientific journals.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords